<SEC-DOCUMENT>0000950142-22-003233-index.html : 20221121
<SEC-HEADER>0000950142-22-003233.hdr.sgml : 20221121
<ACCEPTANCE-DATETIME>20221121175823
ACCESSION NUMBER:		0000950142-22-003233
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20221021
FILED AS OF DATE:		20221121
DATE AS OF CHANGE:		20221121

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Hurvitz Chaim
		CENTRAL INDEX KEY:			0001630542

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38302
		FILM NUMBER:		221406941

	MAIL ADDRESS:	
		STREET 1:		C/O GALMED PHARMACEUTICALS LTD., 8 SHAUL
		STREET 2:		HAMELECH BLVD, AMOT HAMISHPAT BLDG.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			64733

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NRX Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001719406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				822844431
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1201 ORANGE STREET
		STREET 2:		SUITE 600
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19801
		BUSINESS PHONE:		484-254-6134

	MAIL ADDRESS:	
		STREET 1:		1201 ORANGE STREET
		STREET 2:		SUITE 600
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Big Rock Partners Acquisition Corp.
		DATE OF NAME CHANGE:	20171012
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>es220307158_4-hurvitz.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: es220307158_4-hurvitz.html

Document 1 - RAW XML: es220307158_4-hurvitz.xml

</DOCUMENT>
</SEC-DOCUMENT>